Skip to main content
. Author manuscript; available in PMC: 2014 Jan 8.
Published in final edited form as: AJR Am J Roentgenol. 2008 Dec;191(6):10.2214/AJR.07.3693. doi: 10.2214/AJR.07.3693

TABLE 1. Sensitivity of Molecular Breast Imaging as a Function of Tumor Histopathology for Each of Three Blinded Readers.

Reader 1
Reader 2
Reader 3
Histopathology No. of
Tumors
TP FN Sensitivity
(%)
TP FN Sensitivity
(%)
TP FN Sensitivity
(%)

IDC 45 41 4 91 39 6 87 37 8 82
DCIS 17 16 1 94 17 0 100 16 1 94
Mixed IDC and
 DCIS
29 29 0 100 29 0 100 27 2 93
ILC 21 17 4 81 18 3 86 17 4 81
Mixed IDC and
 ILC
11 10 1 91 10 1 91 10 1 91
Tubular
 carcinoma
2 1 1 50 1 1 50 1 1 50
Medullary
 carcinoma
1 1 0 100 1 0 100 1 0 100
Metaplastic
 carcinoma
1 1 0 100 1 0 100 1 0 100
Malignant
 phyllodes tumor
1 1 0 100 1 0 100 1 0 100

Total 128 117 11 91 117 11 91 111 17 87

Note—A total of 128 tumors were present in 88 patients with breast cancer. TP = true-positive, FN = false-negative, IDC = invasive ductal carcinoma, DCIS = ductal carcinoma in situ, ILC = invasive lobular carcinoma.